Research Directory

Progressive increase in oncology drug approvals

Read more

Checkpoint inhibitors are focus at ESMO

Read more

ASCO delivers new cancer data - and one surprise

Read more

Oncology Review: A positive trajectory for approvals

Read more

Oncology drug approvals rise, with help from China

Read more

Checkpoint Inhibitors: A decade of innovation

Read more

ESMO 2021: Oncology developers present their findings

Read more

Oncology approvals rise, driven by novel compounds

Read more

Drug development robust, despite the pandemic

Read more

Oncology approvals are on an upward trend

Read more